Published in Exp Dermatol on May 29, 2012
Desmosome assembly and dynamics. Trends Cell Biol (2013) 0.96
Overlapping ATP2C1 and ASTE1 genes in human genome: implications for SPCA1 expression? Int J Mol Sci (2013) 0.78
Cell-cell adhesions and cell contractility are upregulated upon desmosome disruption. PLoS One (2014) 0.77
Rab3Gap1 mediates exocytosis of Claudin-1 and tight junction formation during epidermal barrier acquisition. Dev Biol (2013) 0.76
ATP2C1 gene mutations in Hailey-Hailey disease and possible roles of SPCA1 isoforms in membrane trafficking. Cell Death Dis (2016) 0.75
Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc (2008) 62.52
Normalization of cDNA microarray data. Methods (2003) 18.69
Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice. J Cell Biol (2002) 5.51
Calcium-regulated differentiation of normal human epidermal keratinocytes in chemically defined clonal culture and serum-free serial culture. J Invest Dermatol (1983) 5.05
Quantifying Western blots: pitfalls of densitometry. Electrophoresis (2009) 2.25
Mutations in ATP2C1, encoding a calcium pump, cause Hailey-Hailey disease. Nat Genet (2000) 2.09
Hailey-Hailey disease: the clinical features, response to treatment and prognosis. Br J Dermatol (1992) 1.61
Permeability barrier dysfunction in transgenic mice overexpressing claudin 6. Development (2002) 1.51
Organization and formation of the tight junction system in human epidermis and cultured keratinocytes. Eur J Cell Biol (2002) 1.45
Epidermal tight junctions: ZO-1 and occludin are expressed in mature, developing, and affected skin and in vitro differentiating keratinocytes. J Invest Dermatol (2001) 1.37
Hailey-Hailey disease is caused by mutations in ATP2C1 encoding a novel Ca(2+) pump. Hum Mol Genet (2000) 1.20
Human keratinocyte ATP2C1 localizes to the Golgi and controls Golgi Ca2+ stores. J Invest Dermatol (2003) 1.19
Increased expression of Dsg2 in malignant skin carcinomas: A tissue-microarray based study. Cell Adh Migr (2009) 1.15
Desmosomes at a glance. J Cell Sci (2009) 1.14
Generation of monoclonal antibodies specific for desmoglein family members. Hybrid Hybridomics (2002) 1.10
Transport via the regulated secretory pathway in semi-intact PC12 cells: role of intra-cisternal calcium and pH in the transport and sorting of secretogranin II. J Cell Biol (1994) 1.09
SPCA1 pumps and Hailey-Hailey disease. Biochem Biophys Res Commun (2004) 1.08
Tight junction components occludin, ZO-1, and claudin-1, -4 and -5 in active and healing psoriasis. Br J Dermatol (2007) 1.05
An immunohistological study of desmosomes in Darier's disease and Hailey-Hailey disease. Br J Dermatol (1991) 1.02
Reevaluation of the normal epidermal calcium gradient, and analysis of calcium levels and ATP receptors in Hailey-Hailey and Darier epidermis. J Invest Dermatol (2008) 1.00
Oxidative stress activation of miR-125b is part of the molecular switch for Hailey-Hailey disease manifestation. Exp Dermatol (2011) 1.00
Calcium pump disorders of the skin. Am J Med Genet C Semin Med Genet (2004) 0.99
Dissociation of intra- and extracellular domains of desmosomal cadherins and E-cadherin in Hailey-Hailey disease and Darier's disease. Br J Dermatol (2000) 0.99
Deficiency of ATP2C1, a Golgi ion pump, induces secretory pathway defects in endoplasmic reticulum (ER)-associated degradation and sensitivity to ER stress. J Biol Chem (2004) 0.96
Delayed epidermal permeability barrier formation and hair follicle aberrations in Inv-Cldn6 mice. Mech Dev (2005) 0.96
Keratinocytes cultured from patients with Hailey-Hailey disease and Darier disease display distinct patterns of calcium regulation. Br J Dermatol (2005) 0.85
Tight junctions in Hailey-Hailey and Darier's diseases. Dermatol Reports (2009) 0.80
Compound heterozygous desmoplakin mutations result in a phenotype with a combination of myocardial, skin, hair, and enamel abnormalities. J Invest Dermatol (2009) 1.62
Protein kinase C (PKC) family in cancer progression. Cancer Lett (2006) 1.54
Prevalence of acute mountain sickness among Finnish trekkers on Mount Kilimanjaro, Tanzania: an observational study. High Alt Med Biol (2008) 1.54
Influence of a combination of Lactobacillus acidophilus NCFM and lactitol on healthy elderly: intestinal and immune parameters. Br J Nutr (2008) 1.34
Decreased bone mineral density and content in neurofibromatosis type 1: lowest local values are located in the load-carrying parts of the body. Osteoporos Int (2004) 1.31
Vascular endothelial growth factor-C accelerates diabetic wound healing. Am J Pathol (2006) 1.30
Expression profiles and clinical correlations of degradome components in the tumor microenvironment of head and neck squamous cell carcinoma. Clin Cancer Res (2010) 1.22
Protein kinase C alpha/beta inhibitor Go6976 promotes formation of cell junctions and inhibits invasion of urinary bladder carcinoma cells. Cancer Res (2004) 1.21
The pathoetiology of neurofibromatosis 1. Am J Pathol (2011) 1.13
Class III beta-tubulin is a component of the mitotic spindle in multiple cell types. J Histochem Cytochem (2008) 1.09
NF1 tumor suppressor protein and mRNA in skeletal tissues of developing and adult normal mouse and NF1-deficient embryos. J Bone Miner Res (2004) 1.05
The development of cutaneous neurofibromas. Am J Pathol (2011) 1.04
Growth factor therapy and autologous lymph node transfer in lymphedema. Circulation (2011) 1.01
Reevaluation of the normal epidermal calcium gradient, and analysis of calcium levels and ATP receptors in Hailey-Hailey and Darier epidermis. J Invest Dermatol (2008) 1.00
Skeletal abnormalities in neurofibromatosis type 1: approaches to therapeutic options. Am J Med Genet A (2009) 1.00
Myelination in mouse dorsal root ganglion/Schwann cell cocultures. Mol Cell Neurosci (2007) 0.99
Autosomal dominant diabetes arising from a Wolfram syndrome 1 mutation. Diabetes (2013) 0.99
Serpin peptidase inhibitor clade A member 1 (SerpinA1) is a novel biomarker for progression of cutaneous squamous cell carcinoma. Am J Pathol (2011) 0.97
Legius syndrome in fourteen families. Hum Mutat (2011) 0.95
Sentinel lymph node biopsy in cutaneous melanoma: a case-control study. Ann Surg Oncol (2007) 0.94
Quality of life after free-flap reconstruction in patients with oral and pharyngeal cancer. Head Neck (2006) 0.93
Isolation, purification and expansion of myelination-competent, neonatal mouse Schwann cells. Eur J Neurosci (2007) 0.93
Oral soft tissue alterations in patients with neurofibromatosis. Clin Oral Investig (2011) 0.92
HCR, a candidate gene for psoriasis, is expressed differently in psoriasis and other hyperproliferative skin disorders and is downregulated by interferon-gamma in keratinocytes. J Invest Dermatol (2003) 0.91
Congenital pseudarthrosis of neurofibromatosis type 1: impaired osteoblast differentiation and function and altered NF1 gene expression. Bone (2008) 0.90
Osteoclasts in neurofibromatosis type 1 display enhanced resorption capacity, aberrant morphology, and resistance to serum deprivation. Bone (2010) 0.90
Effect of polydextrose on intestinal microbes and immune functions in pigs. Br J Nutr (2007) 0.89
PKC inhibitor Go6976 induces mitosis and enhances doxorubicin-paclitaxel cytotoxicity in urinary bladder carcinoma cells. Cancer Lett (2007) 0.87
Neurofibromatosis 1 and dental caries. Clin Oral Investig (2009) 0.86
Alternatively used promoters and distinct elements direct tissue-specific expression of nephrin. J Am Soc Nephrol (2003) 0.86
Efficacy of mesotherapy in facial rejuvenation: a histological and immunohistochemical evaluation. Int J Dermatol (2012) 0.85
NF1 gene expression in mouse fracture healing and in experimental rat pseudarthrosis. J Histochem Cytochem (2005) 0.85
Restricted distribution of mRNAs encoding a sarcoplasmic reticulum or transverse tubule protein in skeletal myofibers. J Histochem Cytochem (2005) 0.85
Back to the future: proceedings from the 2010 NF Conference. Am J Med Genet A (2010) 0.84
Neurofibromatosis type 1 gene mutation analysis using sequence capture and high-throughput sequencing. Acta Derm Venereol (2014) 0.84
Radiographic findings in the jaws of patients with neurofibromatosis 1. J Oral Maxillofac Surg (2012) 0.84
Periapical cemental dysplasia is common in women with NF1. Eur J Med Genet (2007) 0.84
Tight junction proteins in human Schwann cell autotypic junctions. J Histochem Cytochem (2009) 0.83
In vivo single-molecule kinetics of activation and subsequent activity of the arabinose promoter. Nucleic Acids Res (2013) 0.83
NF1 tumor suppressor mRNA is targeted to the cell-cell contact zone in Ca(2+)-induced keratinocyte differentiation. Lab Invest (2002) 0.83
Matrix metalloproteinase-19 is expressed by keratinocytes in psoriasis. Acta Derm Venereol (2003) 0.83
A controlled register-based study of 460 neurofibromatosis 1 patients: increased fracture risk in children and adults over 41 years of age. J Bone Miner Res (2012) 0.82
Altered calcium-mediated cell signaling in keratinocytes cultured from patients with neurofibromatosis type 1. Am J Pathol (2002) 0.82
Hexose sugars differentially alter collagen gene expression and synthesis in fibroblasts derived from granulation tissue, hypertrophic scar and keloid. Arch Dermatol Res (2004) 0.82
Keratinocyte growth factor induces gene expression signature associated with suppression of malignant phenotype of cutaneous squamous carcinoma cells. PLoS One (2012) 0.82
Effects of the Nd:YAG 1320-nm laser on skin rejuvenation: clinical and histological correlations. J Cosmet Laser Ther (2011) 0.81
Heterogeneity of cellular proliferation within transitional cell carcinoma: correlation of protein kinase C alpha/betaI expression and activity. J Histochem Cytochem (2006) 0.81
Vasculopathy in two cases of NF1-related congenital pseudarthrosis. Pathol Res Pract (2006) 0.81
Swallowing after free-flap reconstruction in patients with oral and pharyngeal cancer. Oral Oncol (2005) 0.81
p38δ mitogen-activated protein kinase regulates the expression of tight junction protein ZO-1 in differentiating human epidermal keratinocytes. Arch Dermatol Res (2013) 0.81
Brooke-Spiegler syndrome associated with ulcerative rectosigmoiditis. Acta Derm Venereol (2013) 0.80
Short mandible, maxilla and cranial base are common in patients with neurofibromatosis 1. Eur J Oral Sci (2011) 0.80
Lipid rafts and detergent-resistant membranes in epithelial keratinocytes. Methods Mol Biol (2014) 0.78
Desire for body contouring surgery after bariatric surgery: do body mass index and weight loss matter? Aesthet Surg J (2013) 0.78
Targeted treatment for lymphedema and lymphatic metastasis. Ann N Y Acad Sci (2008) 0.78
Functional expression of NF1 tumor suppressor protein: association with keratin intermediate filaments during the early development of human epidermis. BMC Dermatol (2002) 0.78
Remodeling of the tibia after grafting of a large cavity with particulate bioactive glass-hydroxylapatite--case report on treatment of fibrous dysplasia with 13 years' follow-up. Acta Orthop Scand (2003) 0.77
Physical discomfort due to redundant skin in post-bariatric surgery patients. J Plast Reconstr Aesthet Surg (2013) 0.77
Speech characteristics in neurofibromatosis type 1. Am J Med Genet A (2010) 0.77
Multiple minimally invasive Erbium: Yttrium Aluminum Garnet laser mini-peels for skin rejuvenation: an objective assessment. J Cosmet Dermatol (2012) 0.77
An intact actin-containing cytoskeleton is required for capacitative calcium entry, but not for ATP-induced calcium-mediated cell signaling in cultured human keratinocytes. Med Sci Monit (2003) 0.77
Sentinel node metastasectomy in thin <or=1-mm melanoma. Langenbecks Arch Surg (2005) 0.77
Plasminogen activators and their inhibitor gene expression in cutaneous NF1-related neurofibromas. Arch Dermatol Res (2006) 0.77
Expression of transforming growth factor-β after different non-invasive facial rejuvenation modalities. Int J Dermatol (2014) 0.77
Osteoclasts derived from patients with neurofibromatosis 1 (NF1) display insensitivity to bisphosphonates in vitro. Bone (2011) 0.77
Hypoxic conditions stimulate the release of B-type natriuretic peptide from human retinal pigment epithelium cell culture. Acta Ophthalmol (2014) 0.77
Recent developments in neurofibromatoses and RASopathies: management, diagnosis and current and future therapeutic avenues. Am J Med Genet A (2014) 0.76
Desmosomes in developing human epidermis. Dermatol Res Pract (2010) 0.76
Impaired gap junction formation and intercellular calcium signaling in urinary bladder cancer cells can be improved by Gö6976. Cell Commun Adhes (2007) 0.76
The limitations of tissue-oxygen measurement and positron emission tomography as additional methods for postoperative breast reconstruction free-flap monitoring. J Plast Reconstr Aesthet Surg (2008) 0.76
NF1 tumor suppressor in epidermal wound healing with special focus on wound healing in patients with type 1 neurofibromatosis. Arch Dermatol Res (2005) 0.76
Phenotypic characterization of transgenic mice harboring Nf1+/- or Nf1-/- osteoclasts in otherwise Nf1+/+ background. J Cell Biochem (2012) 0.76
Changes in articulatory proficiency following microvascular reconstruction in oral or oropharyngeal cancer. Oral Oncol (2006) 0.75
The effect of extracellular calcium concentration on calcium-mediated cell signaling in NF1 tumor suppressor-deficient keratinocytes. Arch Dermatol Res (2005) 0.75
Lactobacillus acidophilus 74-2 and butyrate induce cyclooxygenase (COX)-1 expression in gastric cancer cells. Immunopharmacol Immunotoxicol (2008) 0.75